Konsyl capsules review: label and availability
Read the label quantities, the limits of the availability check and the answer to discontinuation searches.
Public-source editorial research. Full source dates and access limits remain with the references; no clinical review or product testing is claimed.
Konsyl’s Daily Psyllium Fiber Capsules put a familiar ingredient in an on-the-go format. The manufacturer names psyllium husk powder and a vegetable capsule and marks the product vegan, non-GMO, gluten-free and sugar-free.
The page also promotes weight-management and blood-sugar support and directly mentions GLP-1 digestive side effects. This review separates that advertising from the disclosed preparation. A fiber product’s brand history or convenience does not establish a personalized answer to medicine-related constipation or bloating.
On this page
The panel resolves fiber quantities; GLP-1 benefit and retail stock remain unverified.
The filling and format are identifiable
The official Konsyl page describes psyllium husk powder inside a vegetable capsule. The listing identifies SKU DS9501B and provides a separate product description. That makes the capsule product recognizable without borrowing facts from Konsyl’s loose powders or other formulations.
The phrase “one simple ingredient” refers to the fiber filling; the page separately acknowledges a capsule. Its exact shell chemistry is not specified in the readable declaration. A clear comparison should retain that distinction rather than assume a particular cellulose derivative. The format guide explains why a product’s physical preparation remains relevant even when the fiber source is familiar.
The current capsule panel
The 200-count panel identifies the front-label 500 mg as psyllium per capsule. Label.
| Label item | Printed amount |
|---|---|
| Capsules per serving | 3 |
| Servings per container | About 66 |
| Dietary fiber | 1 g |
| Soluble fiber | 1 g |
| Insoluble fiber | 0.3 g |
| Psyllium seed husk | 1.5 g |
The printed total remains 1 g; adding rounded components would misrepresent it.
The count-and-days guide shows why these numbers should remain separate. Counting capsules is useful for shopping, but it cannot determine a personally appropriate plan.
GLP-1 advertising should not become a treatment claim
Konsyl explicitly promotes relief of GLP-1 digestive side effects such as occasional constipation and bloating. That is the manufacturer’s product claim. The page used here does not provide a controlled trial of these exact capsules in people taking a specified GLP-1 medicine with a defined symptom endpoint.
A broad claim about a familiar fiber is not enough to conclude that it prevents or treats a medicine’s effects for an individual. FDA’s supplement explanation clarifies that supplements are generally not approved for safety and effectiveness before marketing. The category chapter helps keep supplement positioning separate from medicine authorization.
Brand longevity is not finished-product proof
The product page emphasizes Konsyl’s long history and experience in digestive products. That can help establish who is making the offer. It does not demonstrate that every current preparation has been tested for every advertised outcome or that a long-established brand works better for every person.
The seller also discusses regularity, fullness and maintaining healthy blood sugar. These remain attributed descriptions, rather than observations made by this publication. No firsthand capsule testing or clinician signoff is claimed. An ingredient source, a company history and a finished-product clinical result are different kinds of information, and a readable review should not blend them together.
Dietary labels have narrower meanings than universal tolerance
Konsyl marks the capsules vegan, non-GMO, gluten-free and sugar-free. Those are useful product characteristics for comparing preferences. They are not proof that every person will avoid gas, sensitivity or swallowing difficulty. A “plant-based” phrase similarly does not decide a medical question.
NIH’s supplement overview explains that supplements can have effects and interactions and cannot replace a varied diet or appropriate care. That independent context is particularly relevant when a product combines broad wellness claims with a short ingredient story. The benefit is greater clarity about what is being sold, not a guarantee of an individual result.
The cautions deserve space beside convenience
The manufacturer includes cautions about medicines, medical care and pregnancy or lactation and points to the label’s consumption warnings. MedlinePlus independently describes psyllium-related swallowing and allergy concerns. The sources do not assess a particular reader’s symptoms or authorize a supplement schedule.
The medicine-and-swallowing guide helps distinguish those concerns from portability. This review does not repeat capsule doses, fluid amounts or storage directions. It also does not claim a safe handoff between a GLP-1 prescriber and the manufacturer. Customer purchasing support is not the same as medical monitoring.
For everyday-use questions, discuss persistent symptoms and medicines with a clinician; the facts panel cannot choose your routine.
Are Konsyl capsules discontinued?
The official listing linked retailers on November 8. Discontinuation, production and stock were not verified. Capsule and powder records remain separate.
The Organic India psyllium review and Yerba Prima capsule review offer other product descriptions to read. They are separate comparisons rather than substitutes selected for a person. A medical question remains a medical question even when several shopping pages use the same fiber name.
Sources behind the wording
Konsyl: Daily Psyllium Fiber Capsules
Manufacturer product/label declaration and attributed claims; no independent assay or clinical signoff
Checked 2026-10-01
https://konsyl.com/product/konsyl-daily-psyllium-fiber-capsules/FDA: Using Dietary Supplements
Current federal consumer explanation; relevant category and label context, not product endorsement
Checked 2026-10-01
https://www.fda.gov/food/dietary-supplements/information-consumers-using-dietary-supplementsNIH Office of Dietary Supplements: What You Need to Know
Current NIH consumer context; selected sections only, not product-specific performance evidence
Checked 2026-10-01
https://ods.od.nih.gov/HealthInformation/DS_WhatYouNeedToKnow.aspxMedlinePlus: Psyllium
Current medical psyllium context; no personal regimen or transfer of medicinal instructions to supplements
Checked 2026-10-01
https://medlineplus.gov/druginfo/meds/a601104.htmlKonsyl label
Manufacturer label record.
Checked 2026-11-08
https://konsyl.com/product/konsyl-daily-psyllium-fiber-capsules/